Stacey Cranert

544 total citations
15 papers, 322 citations indexed

About

Stacey Cranert is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Stacey Cranert has authored 15 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Stacey Cranert's work include CAR-T cell therapy research (11 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (5 papers). Stacey Cranert is often cited by papers focused on CAR-T cell therapy research (11 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (5 papers). Stacey Cranert collaborates with scholars based in United States and Canada. Stacey Cranert's co-authors include Stephen N. Waggoner, Carolyn E. Rydyznski, Ivayla E. Gyurova, Sarah E. Mahl, Michael T. Moran, Taylor Brooks, Jonathan P. McNally, Fazeela Yaqoob, Steven H. Kleinstein and Julian Q. Zhou and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Stacey Cranert

13 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stacey Cranert United States 8 186 105 74 40 33 15 322
Ivayla E. Gyurova United States 6 162 0.9× 46 0.4× 66 0.9× 19 0.5× 70 2.1× 10 307
Alizée J Grimm Switzerland 7 105 0.6× 51 0.5× 101 1.4× 32 0.8× 14 0.4× 9 257
Annette E. Sköld Sweden 12 391 2.1× 144 1.4× 138 1.9× 18 0.5× 35 1.1× 16 470
Adam Giermasz United States 7 554 3.0× 143 1.4× 98 1.3× 26 0.7× 33 1.0× 8 611
Michelle Sue Jann Lee Japan 12 182 1.0× 33 0.3× 102 1.4× 17 0.4× 33 1.0× 15 329
Gloria Esteso Spain 13 220 1.2× 83 0.8× 113 1.5× 24 0.6× 38 1.2× 22 383
Sarah Siddiqui Canada 10 236 1.3× 37 0.4× 98 1.3× 18 0.5× 58 1.8× 13 350
Thierry Giffon France 10 258 1.4× 40 0.4× 80 1.1× 26 0.7× 76 2.3× 19 359
David I. Weiss United States 7 184 1.0× 46 0.4× 140 1.9× 12 0.3× 53 1.6× 7 353
Ruth Simmons United Kingdom 8 90 0.5× 58 0.6× 64 0.9× 51 1.3× 63 1.9× 10 314

Countries citing papers authored by Stacey Cranert

Since Specialization
Citations

This map shows the geographic impact of Stacey Cranert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey Cranert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey Cranert more than expected).

Fields of papers citing papers by Stacey Cranert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacey Cranert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey Cranert. The network helps show where Stacey Cranert may publish in the future.

Co-authorship network of co-authors of Stacey Cranert

This figure shows the co-authorship network connecting the top 25 collaborators of Stacey Cranert. A scholar is included among the top collaborators of Stacey Cranert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacey Cranert. Stacey Cranert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Jambon, Samy, Meixuan Chen, Rajesh Belani, et al.. (2024). P-CD19CD20-ALLO1: Potent Fully Allogeneic CAR-T Therapy Targeting CD19 and CD20 with Superior Efficacy over Single-Target Products. Blood. 144(Supplement 1). 4805–4805.
2.
3.
Haag, Sabrina, Katherine McArthur, Samuel E. DePrimo, et al.. (2024). Abstract CT070: Solid tumor patients require higher cyclophosphamide (cy) dose than multiple myeloma (MM) patients to achieve adequate lymphodepletion (LD) necessary to enable allogeneic CAR-T expansion. Cancer Research. 84(7_Supplement). CT070–CT070. 2 indexed citations
4.
Madison, Blair, Deepak P. Patil, Maximilian Richter, et al.. (2022). Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells. Molecular Therapy — Nucleic Acids. 29. 979–995. 41 indexed citations
5.
Tseng, Hubert, Yan Zhang, Stacey Cranert, et al.. (2021). 147 Memory phenotype in allogeneic anti-BCMA CAR-T cell therapy (P-BCMA-ALLO1) correlates with in vivo tumor control. SHILAP Revista de lepidopterología. A155–A155. 1 indexed citations
6.
Tseng, Hubert, Yan Zhang, Stacey Cranert, et al.. (2021). Memory Phenotype in Allogeneic Anti-BCMA CAR-T Cell Therapy (P-BCMA-ALLO1) Correlates with In Vivo Tumor Control. Blood. 138(Supplement 1). 4802–4802. 5 indexed citations
7.
Cranert, Stacey, Ivayla E. Gyurova, Marat Khodoun, et al.. (2020). Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells. Cell Reports Medicine. 1(1). 100003–100003. 39 indexed citations
8.
9.
10.
Rydyznski, Carolyn E., Stacey Cranert, Julian Q. Zhou, et al.. (2018). Affinity Maturation Is Impaired by Natural Killer Cell Suppression of Germinal Centers. Cell Reports. 24(13). 3367–3373.e4. 55 indexed citations
11.
Wang, Xinxin, Burton E. Barnett, Christopher E. Martin, et al.. (2017). Production of Universal Anti-Bcma CAR-T Cells with Reduced Alloreactivity, but Potent Effector Function for the Treatment of Multiple Myeloma. Blood. 130. 503–503. 3 indexed citations
12.
Guo, Huaijian, Stacey Cranert, Yan Lü, et al.. (2016). Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1. The Journal of Experimental Medicine. 213(10). 2187–2207. 22 indexed citations
13.
Waggoner, Stephen N., Ivayla E. Gyurova, Stacey Cranert, et al.. (2015). Roles of natural killer cells in antiviral immunity. Current Opinion in Virology. 16. 15–23. 117 indexed citations
14.
Cranert, Stacey, et al.. (2014). Tetrahymena Pot2 Is a Developmentally Regulated Paralog of Pot1 That Localizes to Chromosome Breakage Sites but Not to Telomeres. Eukaryotic Cell. 13(12). 1519–1529. 11 indexed citations
15.
Cranert, Stacey, et al.. (2013). The 3′ Overhangs at Tetrahymena thermophila Telomeres Are Packaged by Four Proteins, Pot1a, Tpt1, Pat1, and Pat2. Eukaryotic Cell. 13(2). 240–245. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivayla E. Gyurova Breakdown of academic impact, for papers by Alizée J Grimm Breakdown of academic impact, for papers by Annette E. Sköld Breakdown of academic impact, for papers by Adam Giermasz Breakdown of academic impact, for papers by Michelle Sue Jann Lee Breakdown of academic impact, for papers by Gloria Esteso Breakdown of academic impact, for papers by Sarah Siddiqui Breakdown of academic impact, for papers by Thierry Giffon Breakdown of academic impact, for papers by David I. Weiss Breakdown of academic impact, for papers by Ruth Simmons
Rankless by CCL
2026